Chris Pan

Stock Analyst at Goldman Sachs

(2.05)
# 3,243
Out of 5,073 analysts
41
Total ratings
51.6%
Success rate
1%
Average return

Stocks Rated by Chris Pan

Hangzhou Tigermed Consulting Co., Ltd
Aug 30, 2026
Reiterated: Buy
Price Target: $61.40 → $52.10
Current: $38.56
Upside: +35.11%
AK Medical Holdings Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $8.40 → $7.60
Current: $4.27
Upside: +77.99%
Shandong Weigao Group Medical Polymer Company Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $4.00 → $3.86
Current: $3.18
Upside: +21.38%
MicroTech Medical (Hangzhou) Co., Ltd.
Apr 26, 2026
Upgraded: Hold
Price Target: $6.60 → $8.90
Current: $6.90
Upside: +28.99%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Apr 21, 2026
Initiated Coverage: Buy
Price Target: $45.00
Current: $21.18
Upside: +112.46%
Shenzhen Edge Medical Co., Ltd.
Apr 21, 2026
Initiated Coverage: Buy
Price Target: $81.00
Current: $31.12
Upside: +160.28%
Angelalign Technology Inc.
Aug 26, 2025
Reiterated: Buy
Price Target: $76.20 → $81.30
Current: $78.30
Upside: n/a
Venus Medtech (Hangzhou) Inc.
Sep 6, 2024
Rated: Hold
Price Target: n/a
Current: $1.00
Upside: n/a
Shanghai HeartCare Medical Technology Corporation Limited
Jul 19, 2024
Reiterated: Buy
Price Target: $29.80 → $25.60
Current: $52.50
Upside: n/a
Gushengtang Holdings Limited
Apr 19, 2024
Upgraded: Buy
Price Target: $55.00 → $61.00
Current: $26.72
Upside: n/a